An unusual case of malignant hypomelanotic melanoma occurred in a 15-year-old gray mantle mule with unknown primary site and widespread metastatic growth is described. An ante-mortem examination, the presence of subcutaneous nodules was noted; histologically they are constituted by spindle or polygonal-shaped tumour cells with rare black granules in the cytoplasm; the immunohistochemical procedures showed a large expression of S-100, vimentin and HMB-45 antibodies, suggesting thus a diagnosis of malignant melanoma. Ultrastructural findings, obtained on formalin-fixed paraffin-embedded material, showed characteristic melanosomes and irregular fibrillary centers in nuclei of neoplastic cells. At post-mortem examination, other nodular mostly melanotic lesions were appreciable in lungs, kidneys, brain, liver, pancreas, spleen, lymph nodes and muscles. The importance of immunohistochemical and ultrastructural findings for the differential diagnosis of this neoplasm is emphasized.

Download full-text PDF

Source

Publication Analysis

Top Keywords

malignant hypomelanotic
8
hypomelanotic melanoma
8
immunohistochemical ultrastructural
8
unknown primary
8
primary site
8
site widespread
8
ultrastructural findings
8
melanoma mules
4
mules histologic
4
histologic immunohistochemical
4

Similar Publications

Amelanotic Melanoma-Biochemical and Molecular Induction Pathways.

Int J Mol Sci

October 2024

Department of Molecular and Cellular Biology, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, Poland.

Article Synopsis
  • * Understanding the biochemical and molecular pathways involved in AM can help develop targeted therapies, though there are currently few specific biomarkers for this type of cancer.
  • * Current treatments focus on inhibiting certain genes (like BRAF and c-KIT) and combining therapies, such as BRAF with MAK inhibitors or immune checkpoint inhibitors, to improve patient outcomes.
View Article and Find Full Text PDF

More than one shade of pink as a marker of early amelanotic/hypomelanotic melanoma.

J Dermatol

July 2024

Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

Article Synopsis
  • * The study analyzed 133 digital images of skin lesions diagnosed as either early amelanotic melanoma or non-melanocytic lesions, using assessments by three blinded dermatologists.
  • * Results indicated specific features in lesions (like multiple shades of pink and irregular dots) can significantly increase the likelihood of accurate diagnosis of early amelanotic melanoma compared to non-melanoma lesions.
View Article and Find Full Text PDF

: Amelanotic/hypomelanotic melanomas (AHMs) account for 2-8% of all cutaneous melanomas. Due to their clinical appearance and the lack of specific dermoscopic indicators, AHMs are challenging to diagnose, particularly in thinner cutaneous lesions. The aim of our study was to evaluate the clinicopathological and dermoscopic features of thin AHMs.

View Article and Find Full Text PDF
Article Synopsis
  • A significant portion (2-20%) of cutaneous melanoma cases are diagnosed as amelanotic/hypopigmented melanoma (AHM), which complicates early detection due to their lack of pigmentation.
  • The study investigates mutations in key pigmentation genes linked to albinism and hypopigmentation, revealing that AHM patients have a higher frequency of rare germline variants compared to pigmented melanoma patients.
  • Findings include that specific gene variants associated with red hair pigmentation are common in AHM cases, and some AHM tumors show chromosomal abnormalities related to these pigmentation genes, indicating a genetic basis for the lack of pigmentation in these melanomas.
View Article and Find Full Text PDF

Review of the spectrum of tuberous sclerosis complex: The Saudi Arabian Experience.

Neurosciences (Riyadh)

May 2024

From the College of Medicine (Almuqbil, Aldoohan, Alhinti, Alkhodair, Kashgari, Altwaijri, Alrumayyan), King Saud bin Abdulaziz University for Health Sciences, from King Abdullah International Medical Research Center (Almuqbil, Alkhodair), Ministry of National Guard, from the Division of Pediatric Neurology (Almuqbil Altwaijri, Alrumayyan), Department of Pediatrics, King Abdullah Specialized Children's Hospital, National Guard Health Affairs, from the Department of Family Medicine and Primary Health Care (Abdulmajeed), King Abdulaziz Medical City, from the Division of Pediatric Dermatology (Alkhodair), Department of Pediatrics, King Abdullah Specialized Children's Hospital (KASCH), National Guard Health Affairs, and from Department of Pediatric (Baarmah), King Abdullah Bin Abdulaziz University Hospital, Princess Nourah bint Abdulrahman University, Riyadh, Kingdom of Saudi Arabia.

Objectives: To determine the prevalence of tuberous sclerosis complex (TSC) in the paediatric Saudi population and to characterise the range of clinical symptoms, neurocutaneous findings, neuroimaging results, and complications of the disease.

Methods: A total of 61 genetically confirmed TSC patients from the National Guard Health Affairs (NGHA) in Saudi Arabia were the subject of this retrospective descriptive analysis. The data were presented using descriptive measures.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!